Aminochalcone 4AAF
Aminochalcone 4AAF is a neuroprotective agent that exerts anxiolytic effects through GABAA and 5-HT receptors. Aminochalcone 4AAF has high selectivity for 5-HT3A and 5-HT2C receptors, and stimulates allosteric behavior toward the 5-HT2A receptor. Aminochalcone 4AAF shows hypoglycemic effects and reduces the level of ROS in the liver. Aminochalcone 4AAF delays the clonic stage of the epileptic seizures . Aminochalcone 4AAF can be used in the study of anxiety, hyperglycemia, and seizures.
For research use only. We do not sell to patients.
- CAS No.: 38239-51-9
- Formula: C15H13NO
- Molecular Weight:223.27
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All 5-HT Receptor Isoforms
More
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CCRF-CEM | IC50 |
8.5 μM
Compound: 8a
|
Antiproliferative activity against human CEM cells after 48 hrs by Coulter counting analysis
Antiproliferative activity against human CEM cells after 48 hrs by Coulter counting analysis
|
[PMID: 19250822] |
| DLD-1 | EC50 |
33 μM
Compound: 14
|
Cytotoxicity against human DLD-1 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
Cytotoxicity against human DLD-1 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
|
[PMID: 36356534] |
| FHC | CC50 |
>100 μM
Compound: 14
|
Cytotoxicity against human FHC cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
Cytotoxicity against human FHC cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
|
[PMID: 36356534] |
| FM3A | IC50 |
34 μM
Compound: 8a
|
Antiproliferative activity against mouse FM3A cells after 48 hrs by Coulter counting analysis
Antiproliferative activity against mouse FM3A cells after 48 hrs by Coulter counting analysis
|
[PMID: 19250822] |
| HCT-116 | EC50 |
23 μM
Compound: 14
|
Cytotoxicity against p53-/- human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
Cytotoxicity against p53-/- human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
|
[PMID: 36356534] |
| HCT-116 | EC50 |
27 μM
Compound: 14
|
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
|
[PMID: 36356534] |
| HCT-116 | IC50 |
14.1 μM
Compound: 1
|
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
|
10.1039/C4MD00371C |
| HeLa | IC50 |
7.7 μM
Compound: 8a
|
Antiproliferative activity against human HeLa cells after 48 hrs by Coulter counting analysis
Antiproliferative activity against human HeLa cells after 48 hrs by Coulter counting analysis
|
[PMID: 19250822] |
| HL-60 | IC50 |
6.4 μM
Compound: 1
|
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
|
10.1039/C4MD00371C |
| HT-29 | EC50 |
35 μM
Compound: 14
|
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay
|
[PMID: 36356534] |
| L1210 | IC50 |
14 μM
Compound: 8a
|
Antiproliferative activity against mouse L1210 cells after 48 hrs by Coulter counting analysis
Antiproliferative activity against mouse L1210 cells after 48 hrs by Coulter counting analysis
|
[PMID: 19250822] |
| MOLT-4 | IC50 |
7.9 μM
Compound: 8a
|
Antiproliferative activity against human MOLT4 cells after 48 hrs by Coulter counting analysis
Antiproliferative activity against human MOLT4 cells after 48 hrs by Coulter counting analysis
|
[PMID: 19250822] |
| OVCAR-8 | IC50 |
>22.4 μM
Compound: 1
|
Cytotoxicity against human OVCAR8 cells after 72 hrs by MTT assay
Cytotoxicity against human OVCAR8 cells after 72 hrs by MTT assay
|
10.1039/C4MD00371C |
| PBMC | IC50 |
20.2 μM
Compound: 1
|
Cytotoxicity against human PBMC cells after 72 hrs by MTT assay
Cytotoxicity against human PBMC cells after 72 hrs by MTT assay
|
10.1039/C4MD00371C |
| SF-295 | IC50 |
>22.4 μM
Compound: 1
|
Cytotoxicity against human SF295 cells after 72 hrs by MTT assay
Cytotoxicity against human SF295 cells after 72 hrs by MTT assay
|
10.1039/C4MD00371C |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Adult zebrafish aged between 90 and 120 days, measuring approximately 3.5 cm in length and weighing approximately 0.4 g[1]
-
Dosage:20 μL of 0.1, 0.5, or 10 mg/mL
-
Administration:p.o. for a single dose
-
Result:Showed not toxicity to adult zebrafish (LC50 > 1.0 mg/mL).
Exhibited anxiolytic behavior in novel tank test.
Caused a significant impairment of motor function in open field test and spinning task.
Altered the latency time and the number of crossings between the light and dark sides.
Restored the locomotor pattern when pretreated with Flumazenil (HY-B0009) (0.1 mg/mL).
Reduced the time the fish spent in the light area of the aquarium when pretreated with Cyproheptadine (HY-B1622), Pizotifen (HY-B0115), and Granisetron (HY-B0071).
Increased latency time and reduced the number of crossings from the light to the dark.
Prevented hyperglycemia-induced oxidative stress in liver and brain tissues of adult zebrafish (0.5 mg/mL).
Reversed PTZ-induced convulsive behavior in stage three (1.0 mg/mL).
Chemical Information
-
CAS No. 38239-51-9
-
Molecular Weight 223.27
-
Formula C15H13NO
-
SMILES
NC1=CC=C(C=C1)C(/C=C/C2=CC=CC=C2)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)